Anzeige
Mehr »
Sonntag, 11.01.2026 - Börsentäglich über 12.000 News
Gold-Superzyklus 2026: Der Countdown zu einer der heißesten Gold-Stories 2026 hat begonnen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
46 Leser
Artikel bewerten:
(0)

RaySafe Highlights Real-Time Radiation Dose Monitoring System at CIRSE 2015

RaySafe i2 Dosimeter to be demonstrated at the CIRSE Radiation Protection Pavilion

EVERETT, Washington, Sept. 28, 2015 /PRNewswire/ --Unfors RaySafe Inc., a Fluke Biomedical company and the leading manufacturer of real-time dose monitoring solutions for high-dose labs, will educate interventional radiologists about measuring and reducing their own radiation dose at the 30th annual Cardiovascular and Interventional Radiological Society of Europe (CIRSE) September 26-30 in Libson, Portugal.

Logo- http://photos.prnewswire.com/prnh/20150304/179432LOGO

CIRSE attendees will learn the significant benefits the RaySafe i2 can offer interventional radiologists, electrophysiologists, interventional cardiologists and other clinical staff for reducing radiation dose, Excess radiation has been connected with the development of harmful medical conditions such as cataracts and even brain tumors. The RaySafe i2 active dosimetry system gives real-time insight about personal radiation exposure, allowing medical staff to change their behavior in order to minimize their exposure.

"Based on my own experiences in working with ionizing radiation throughout my career, I feel that it is critical that physicians, nurses but alsohospital administrators understand the serious health consequences that can and do result from long-term exposure to radiation," said Professor Böckler,University Hospital Heidelberg, Department of Vascular and Endovascular Surgery. "European healthcare facilities are pioneersfor protection against the troubling health consequences that come with excessive radiation exposure and have looked for ways that can guard against this type of exposure and heighten awareness through advanced technologies such as the RaySafe i2."

RaySafe Dose Hero
New this year, all CIRSE attendees will have the opportunity to play the RaySafe Dose Hero. RaySafe has created a quick, interactive game controlled by Xbox-Kinect to test the ability of CIRSE attendees to virtually help a surgeon while avoiding exposure to excessive radiation. In the first round, the player will have to collect tools and hand them to the surgeon during a procedure, thereby moving around the room and encountering radiation at various points. During the second round, the player receives his/her real-time dose feedback from the RaySafe i2, educating them on how much exposure he/she received during the single procedure.

"There is lack of awareness about unnecessary radiation exposure for medical staff in hospitals and clinics. We have implemented the RaySafe Dose Hero so attendees can see their own results of real-time dose feedback from the RaySafe i2," stated Bart LeClou, Director Business Area "Personal Dosimetry" at Unfors RaySafe. "The i2 system gives immediate feedback so corrective action can be taken to help protect every individual in the operating room. Physicians and their clinical teams need advocates to help make cath labs safe in the hospitals and across the world, and we are here to support them."

To learn more about radiation dose safety and real-time dose monitoring, visit the RaySafe booth # RPP4 during CIRSE. Professor Bockler will also be in attendance to discuss both his experiences and insights as it pertains to radiation safety for staff.

About Fluke Biomedical
Trusted for the measurements that matter.
Fluke Biomedical is the premier, global provider of test and measurement equipment and services to the healthcare industry. We serve biomedical engineers, quality-assurance technicians, medical physicists, oncologists and radiation-safety professionals and are continually expanding our range of solutions to a broader range of health and safety professionals. For more information, visit www.flukebiomedical.com.

About Unfors RaySafe, Inc.
Unfors RaySafe, a Fluke Biomedical company, is the leading manufacturer of instruments for the quality assurance and service of diagnostic x-ray equipment and real-time dose monitoring solutions for high-dose labs. Thousands of satisfied medical physicists, service engineers, biomedical engineers, government inspectors and major manufacturers of quality X-ray machines throughout the world use RaySafe products today. For additional information, visit www.raysafe.com and follow us on Facebook and @Unfors_RaySafe.

For more information:
Marissa Confredo
KNB Communications
203-504-8230 ext.135
mconfredo@knbcomm.com

© 2015 PR Newswire
Renditeturbo 2026 - 5 Aktien mit Potenzial
2025 neigt sich dem Ende zu, ohne klassische Jahresendrallye, aber mit einem DAX, der viele Kritiker Lügen gestraft hat. Über 21 Prozent Kursplus seit Jahresbeginn, stärker als der US-Markt. Wer hätte das noch vor Monaten erwartet?

Genau solche Entwicklungen machen den Reiz der Börse aus. Denn auch 2026 dürfte wieder alles anders kommen als gedacht. Während viele Analysten weiter steigende Kurse erwarten, rückt eine zentrale Frage in den Fokus: Wo entstehen im kommenden Jahr echte Überraschungen, und wie kann man davon profitieren?

Unser aktueller Spezialreport beleuchtet fünf Entwicklungen, mit denen kaum jemand rechnet, die aber enormes Renditepotenzial bergen. Vom Comeback der Ölwerte über unterschätzte Plattform-Aktien bis hin zur möglichen Wachablösung im KI-Sektor: Wer 2026 überdurchschnittlich abschneiden will, muss antizyklisch denken und frühzeitig Position beziehen.

Im kostenlosen Report stellen wir 5 Aktien vor, die 2026 im Zentrum solcher Wendepunkte stehen könnten. Solide bewertet, gut positioniert und mit überraschend starkem Momentum.

Jetzt kostenlos herunterladen! Bevor andere erkennen, wo die Chancen wirklich liegen!

Dieses exklusive PDF ist nur für kurze Zeit verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.